THG insider buying and SEC filings, explained
Hanover Insurance Group, Inc. · CIK 944695
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$6.6M
Planned sales (10b5-1)
$4.6M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Aug 19–20, 2026 | Planned (10b5-1) | Dennis Francis Kerrigan (Executive Vice President) sold 8,655 shares between Aug 19 and Aug 20 at about $221.19 ($1.9M), marked as a 10b5-1 plan trade. Holdings down 42% to 12,003 shares. | SEC filing Filed Aug 21, 2026 |
| Aug 5–6, 2026 | Sale | Theodore H Bunting JR (Director) sold 1,200 shares between Aug 5 and Aug 6 at about $229.12 ($275K). Holdings down 17% to 5,835 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 7, 2026 |
| Aug 3, 2026 | Sale | Jane D Carlin (Director) sold 1,000 shares at $231.50 ($232K). Holdings down 31% to 2,270 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 4, 2026 |
| May 21, 2026 | Sale | Francisco Aristeguieta (Director) sold 1,000 shares at $195.37 ($195K). Holdings down 20% to 4,053 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 26, 2026 |
| May 20, 2026 | Planned (10b5-1) | John C Roche (CEO and Director) sold 8,358 shares at about $193.74 ($1.6M), marked as a 10b5-1 plan trade. Holdings down 6% to 141,011 shares. | SEC filing Filed May 21, 2026 |
| May 18, 2026 | Planned (10b5-1) | John C Roche (CEO and Director) sold 5,251 shares at about $198.06 ($1.0M), marked as a 10b5-1 plan trade. Holdings down 4% to 141,011 shares. | SEC filing Filed May 19, 2026 |
| May 8, 2026 | Sale | Denise Lowsley (Executive Vice President) sold 1,062 shares at $188.43 ($200K). Holdings down 21% to 3,883 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 11, 2026 |
| May 4, 2026 | Sale | Willard T Lee (Executive Vice President) sold 1,000 shares at $183.93 ($184K). Holdings down 14% to 5,982 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 5, 2026 |
| May 1, 2026 | Sale | Cynthia Egan (Director) sold 3,400 shares at $188.50 ($641K). Holdings down 27% to 9,359 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 4, 2026 |
| Feb 27, 2026 | Sale | Jane D Carlin (Director) sold 1,200 shares at about $180.91 ($217K). Holdings down 33% to 2,423 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 2, 2026 |
| Feb 5, 2026 | Sale | Richard W. Lavey (Executive Vice President) sold 24,420 shares at about $178.92 ($4.4M). Holdings down 43% to 32,174 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 6, 2026 |
| Nov 12, 2025 | Sale | Denise Lowsley (Executive Vice President) sold 1,619 shares at $181.47 ($294K). Holdings down 32% to 3,512 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 13, 2025 |
96 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow THG in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.